Skip to content

Endoscopic BougieCap dilation for benign esophageal strictures: a feasibility study in daily practice

Endoscopic BougieCap dilation for benign esophageal strictures: a feasibility study in daily practice

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27219
Enrollment
30
Registered
2019-01-21
Start date
2019-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign esophageal stricture

Interventions

Endoscopic dilation with the BougieCap dilator. In sequential dilation procedure the benign stricture will be dilated up to 18 mm. BougieCap dilator: an endoscopic attachment cap intended to be used

Sponsors

Radboud university medical center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Patients presenting with first episode of dysphagia due to benign esophageal stricture requiring repeated EBD to 18 mm - Dysphagia due to benign esophageal stricture (e.g. post-surgery, radiation therapy, caustic ingestion, peptic, post-endotherapy) - Dysphagia for solid, semisolid or liquid food (Ogilvie dysphagia score: 2-4) - Written informed consent

Exclusion criteria

Exclusion criteria: - Patient with a known eosinophilic esophagitis or motility disorder (e.g. achalasia) - Patients with a known or suspected malignant esophageal stricture - Patients with a benign stricture due to a previously performed laryngectomy

Design outcomes

Primary

MeasureTime frame
The main endpoint is the feasibility of EBD with the BougieCap dilator in patients with benign esopahgeal strictures. Feasibility is defined as: - technical success of repeated EBD to 18mm with the BougieCap dilator according to standard practice for EBD

Secondary

MeasureTime frame
- Single EBD procedure time - Total number of EBD procdures with the BougieCap dilator - Recurrent dysphagia (Ogilvie 2-4) during follow-up of 12 weeks

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)